
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Fintech Ecosystem Development Corporation | NASDAQ:FEXD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.86 | 10.60 | 11.43 | 0 | 00:00:00 |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware |
001-40914 |
86-2438985 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) | ||
100 Springhouse Drive, Suite 204 Collegeville, A |
19426 | |||
(Address of principal executive offices) |
(Zip Code) |
Title of each Class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one share of Class A common stock, $0.0001 par value, one right, and one-half of one redeemable warrant |
FEXDU |
The Nasdaq Stock Market LLC | ||
Class A Common stock, par value $0.0001 per share |
FEXD |
The Nasdaq Stock Market LLC | ||
Rights included as part of the units Warrants, each whole warrant exercisable for |
FEXDR |
The Nasdaq Stock Market LLC | ||
one share of Class A common stock at an exercise price of $11.50 per share |
FEXDW |
The Nasdaq Stock Market LLC |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Page No. |
||||||
1 | ||||||
Item 1. |
1 | |||||
1 | ||||||
2 | ||||||
3 | ||||||
4 | ||||||
5 | ||||||
Item 2. |
21 | |||||
Item 3. |
25 | |||||
Item 4. |
25 | |||||
26 | ||||||
Item 1. |
26 | |||||
Item 1A. |
26 | |||||
Item 2. |
26 | |||||
Item 3. |
26 | |||||
Item 4. |
26 | |||||
Item 5. |
26 | |||||
Item 6. |
27 | |||||
28 |
Item 1. |
Financial Information |
March 31, 2022 |
December 31, 2021 |
|||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | 198,124 | $ | 612,750 | ||||
Prepaid expenses |
139,148 | 86,557 | ||||||
Total Current Assets |
337,272 | 699,307 | ||||||
Long-term prepaid expenses |
25,754 | 38,633 | ||||||
Cash held-in Trust Account |
116,163,809 | 116,152,113 | ||||||
Total Assets |
$ |
116,526,835 |
$ |
116,890,053 |
||||
LIABILITIES AND STOCKHOLDERS’ DEFICIT |
||||||||
Current liabilities |
||||||||
Accounts payable and accrued liabilities |
$ | 10,400 | $ | 179,371 | ||||
Total Current Liabilities |
10,400 |
179,371 |
||||||
Derivative Forward purchase liability |
1,887,939 | 1,726,908 | ||||||
Derivative Warrant liabilities |
1,997,358 | 3,706,098 | ||||||
Deferred underwrite fee payable |
3,737,500 | 3,737,500 | ||||||
Total Liabilities |
7,633,197 |
9,349,877 |
||||||
COMMITMENTS AND CONTINGENCIES (NOTE 6) |
||||||||
Class A common stock subject to possible redemption; 11,500,000 shares at redemption value of $10.10 per share |
116,150,000 | 116,150,000 | ||||||
Stockholders’ Deficit: |
||||||||
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding |
— | — | ||||||
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 57,500 representative shares issued and outstanding (excludes 11,500,000 shares subject to redemption) |
6 | 6 | ||||||
Class B Common Stock, par value $0.0001; 20,000,000 shares authorized; 2,875,000 issued and outstanding |
288 | 288 | ||||||
Additional paid-in capital |
— | — | ||||||
Accumulated deficit |
(7,256,656 | ) | (8,610,118 | ) | ||||
Total Stockholders’ Deficit |
(7,256,362 |
) |
(8,609,824 |
) | ||||
Total Liabilities and Stockholders’ Deficit |
$ |
116,526,835 |
$ |
116,890,053 |
||||
Three months ended March 31, 2022 |
From March 5, 2021 (inception) to March 31, 2021 |
|||||||
Operating Expenses: |
||||||||
Formation and Operating Costs |
$ | 205,943 | $ | 851 | ||||
Total operating expenses |
205,943 |
851 |
||||||
Other Income (Expenses): |
||||||||
Change in fair value of derivative warrant liabilities |
1,708,740 | — | ||||||
Change in fair value of derivative forward purchase liability |
(161,031 | ) | — | |||||
Income from investments held in Trust Account |
11,696 | — | ||||||
Total other income (expenses), net |
1,559,405 |
— | ||||||
Net income (loss) |
$ |
1,353,462 |
$ |
(851 |
) | |||
Basic & diluted net loss per share (Class A) |
$ | 0.09 | $ | — | ||||
Weighted average number of ordinary shares-basic and diluted (Class A) |
11,557,500 | — | ||||||
Basic & diluted net loss per share (Class B) |
$ | 0.09 | $ | (0.00 | ) | |||
Weighted average number of ordinary shares-basic and diluted (Class B) 1 |
2,875,000 | 2,500,000 |
1. |
For the period from March 5, 2021 (inception) to March 31, 2021, this excludes an aggregate of 375,000 shares of common stock subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part. |
Common Stock |
||||||||||||||||||||||||||||
Class A |
Class B |
Additional Paid-in Capital |
Accumulated Deficit |
Total |
||||||||||||||||||||||||
Shares |
Amount |
Share |
Amount |
|||||||||||||||||||||||||
Balance, March 5, 2021 (inception) |
— | $ |
— |
— | $ |
— |
$ |
— |
$ |
— |
$ |
— |
||||||||||||||||
Share issuance – Class B 1 |
— | — | 2,875,000 | 288 | 24,712 | — | 25,000 | |||||||||||||||||||||
Net loss |
— | — | — | — | — | (851 | ) | (851 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
March 31, 2021 |
— | $ |
— |
2,875,000 |
$ |
288 |
$ | 24,712 | $ |
(851 |
) |
$ |
24,149 |
|||||||||||||||
Common Stock |
||||||||||||||||||||||||||||
Class A |
Class B |
Additional Paid-in Capital |
Accumulated Deficit |
Total |
||||||||||||||||||||||||
Shares |
Amount |
Share |
Amount |
|||||||||||||||||||||||||
Balance, December 31, 2021 |
57,500 |
$ |
6 |
2,875,000 |
$ |
288 |
$ |
— |
$ |
(8,610,118 |
) |
$ |
(8,609,824 |
) | ||||||||||||||
Net income |
— | — | — | — | — | 1,353,462 | 1,353,462 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
March 31, 2022 |
57,500 |
$ |
6 |
2,875,000 |
$ |
288 |
$ |
— |
$ |
(7,256,656 |
) |
$ |
(7,256,362 |
) |
1. |
Includes an aggregate of 375,000 shares of common stock subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part. |
Three months ended March 31, 2022 |
From March 5, 2021 (inception) to March 31, 2021 |
|||||||
Cash flows from operating activities: |
||||||||
Net income ( loss) |
$ | 1,353,462 | $ | (851 | ) | |||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Change in fair value of derivative forward purchase liability |
161,031 | — | ||||||
Change in fair value of warrant liabilities |
(1,708,740 | ) | — | |||||
Income from investments held in Trust Account |
(11,696 | ) | — | |||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
(39,712 | ) | — | |||||
Accounts payable and accrued liabilities |
(168,971 | ) | 846 | |||||
|
|
|||||||
Net cash used in operating activities |
$ | (414,626 | ) | $ | (5 | ) | ||
|
|
|||||||
Cash flows from financing activities: |
||||||||
Proceeds from issuance of common shares to Sponsor |
— | 25,000 | ||||||
Payment of offering costs |
— | (20,000 | ) | |||||
|
|
|||||||
Net cash provided by financing activities |
— | 5,000 | ||||||
|
|
|||||||
Net increase in cash |
(414,626 | ) | 4,995 | |||||
Cash, beginning of period |
612,750 | — | ||||||
|
|
|||||||
Cash, end of period |
$ | 198,124 | $ | 4,995 | ||||
|
|
|
|
|||||
Supplemental Disclosures of Noncash Financing Activities |
||||||||
Accrued deferred offering costs |
$ |
— |
$ |
80,000 |
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
Gross proceeds from IPO |
115,000,000 | |||
Less: |
||||
Proceeds allocated to Public Warrants |
(1,380,000 | ) | ||
Class A ordinary share issuance costs |
(6,309,800 | ) | ||
|
|
|||
Plus: |
||||
Accretion of carrying value to redemption value |
8,839,800 | |||
|
|
|||
Class a ordinary shares subject to redemption |
116,150,000 | |||
|
|
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and |
• | if, and only if, the last reported sale price of Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like and for certain issuances of Class A common stock and equity-linked securities as described above) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Public Warrant holders. |
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||
Public Warrants |
$ | — | $ | — | $ | 1,092,500 | ||||||
Private Placement Warrants |
— | — | 904,858 | |||||||||
|
|
|
|
|
|
|||||||
Warrant Liability |
— | — | 1,997,358 | |||||||||
Forward Purchase Agreement Liability |
— | — | 1,887,939 | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | — | $ | — | $ | 3,885,297 | ||||||
|
|
|
|
|
|
Inputs |
Public Warrant |
Private Placement Warrant |
Forward Purchase Units |
|||||||||
Exercise price |
$ | 11.50 | $ | 11.50 | $ | 10.00 | ||||||
Volatility |
6.5 | % | 6.5 | % | 6.5 | % | ||||||
Expected term |
5.75 years | 5.75 years | 0.75 year | |||||||||
Risk-free rate |
1.33 | % | 1.33 | % | 0.09 | % | ||||||
Probability of acquisition |
100.0 | % | 100.0 | % | 100.0 | % | ||||||
Dividend yield |
0 | % | 0 | % | 0 | % |
Inputs |
Public Warrant |
Private Placement Warrant |
Forward Purchase Units |
|||||||||
Exercise price |
$ |
11.50 |
$ |
11.50 |
$ |
10.00 |
||||||
Volatility |
8.4 |
% |
8.4 |
% |
8.4 |
% | ||||||
Expected term |
5.56 years |
5.56 years |
0.56 year |
|||||||||
Risk-free rate |
1.30 |
% |
1.30 |
% |
0.21 |
% | ||||||
Probability of acquisition |
100.0 |
% |
100.0 |
% |
100.0 |
% | ||||||
Dividend yield |
0 |
% |
0 |
% |
0 |
% |
Inputs |
Private Placement Warrant |
Forward Purchase Units |
||||||
Exercise price |
$ | 11.50 | $ | 10.00 | ||||
Volatility |
5.2 | % | 5.2 | % | ||||
Expected term |
5.31 years | 0.31 year | ||||||
Risk-free rate |
2.39 | % | 0.64 | % | ||||
Probability of acquisition |
60.0 | % | 100.0 | % | ||||
Dividend yield |
0 | % | 0 | % |
Private Placement |
Public Warrant |
Total Warrant Liability |
Forward Purchase Agreement |
|||||||||||||
Fair value as of December 31, 2021 |
$ | 1,521,098 | 2,185,000 | 3,706,098 | $ | 1,726,908 | ||||||||||
Change in fair value of warrant liabilities |
(616,240 | ) | (1,092,500 | ) | (1,708,740 | ) | 161,031 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Fair value as of March 31, 2022 |
$ | 904,858 | 1,092,500 | 1,997,358 | $ | 1,887,939 | ||||||||||
|
|
|
|
|
|
|
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
• | may significantly dilute the equity interest of investors in this offering; |
• | may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock; |
• | could cause a change of control if a substantial number of shares of our common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and |
• | may adversely affect prevailing market prices for our common stock, rights, and/or warrants. Similarly, if we issue debt securities, it could result in: |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of such covenants; |
• | our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; |
• | our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding; |
• | our inability to pay dividends on our common stock; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, expenses, capital expenditures, acquisitions, and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry, and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes, and other disadvantages compared to our competitors who have less debt. |
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 4. |
Controls and Procedures |
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors. |
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds |
Item 3. |
Defaults Upon Senior Securities |
Item 4. |
Mine Safety Disclosures |
Item 5. |
Other Information |
Item 6. |
Exhibits. |
* | Filed herewith. |
** | Furnished. |
FINTECH ECOSYSTEM DEVELOPMENT CORP. | ||||||
Date: May 9, 2022 | By: | /s/ Jenny Junkeer | ||||
Name: | Jenny Junkeer | |||||
Title: | Chief Financial Officer |
1 Year Fintech Ecosystem Develo... Chart |
1 Month Fintech Ecosystem Develo... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions